Vaccinomics, adversomics, and the immune response network theory: Individualized vaccinology in the 21st century
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Vaccines, like drugs and medical procedures, are increasingly amenable to individualization or personalization, often based on novel data resulting from high throughput “omics” technologies. As a result of these technologies, 21st century vaccinology will increasingly see the abandonment of a “one size fits all” approach to vaccine dosing and delivery, as well as the abandonment of the empiric “isolate–inactivate–inject” paradigm for vaccine development. In this review, we discuss the immune response network theory and its application to the new field of vaccinomics and adversomics, and illustrate how vaccinomics can lead to new vaccine candidates, new understandings of how vaccines stimulate immune responses, new biomarkers for vaccine response, and facilitate the understanding of what genetic and other factors might be responsible for rare side effects due to vaccines. Perhaps most exciting will be the ability, at a systems biology level, to integrate increasingly complex high throughput data into descriptive and predictive equations for immune responses to vaccines. Herein, we discuss the above with a view toward the future of vaccinology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 1×
“Others have reviewed the influence of the microbiome and metagenetics on immune responses to non-self antigens [41,42], and these data add yet another important dimension to the immune response network theory, but will not be further reviewed here.”
BackgroundThe human microbiome: at the interface of health and disease
Cho, I., & Blaser, M. J. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3182 · Cited by 3,449
DAMPs, PAMPs and alarmins: all we need to know about danger
Bianchi, M. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306164 · Cited by 2,794 · cited 1×
“Over the last several years, innate immunity has begun to take center stage not only for its ability to provide non-specific defenses against pathogens, but also for its ability to recognize and differentiate between diverse bacterial, viral, fungal, and parasitic pathogens [68–70], as well as to prime appropriate ada…”
BackgroundPepe, M. S. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh101 · Cited by 1,276
Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism
Sette, A., & Sidney, J. (1999) · Immunogenetics · doi:10.1007/s002510050594 · Cited by 635 · cited 1×
“When considering peptide-based vaccines for potential use in the majority of the population, a relationship between HLA “supertype” alleles associated with overlapping peptide-binding specificities should be considered [98,99].”
BackgroundNewell, E. W., Sigal, N., Bendall, S. C., Nolan, G. P., & Davis, M. M. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.002 · Cited by 555
Structural vaccinology starts to deliver
Dormitzer, P. R., Grandi, G., & Rappuoli, R. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2893 · Cited by 143 · cited 1×
“Since then, others have also proposed systems-level vaccinology approaches [19,20,24–27].”
BackgroundMaier, D. A., Brennan, A. L., Jiang, S., Binder-Scholl, G. K., Lee, G., Plesa, G., Zheng, Z., Cotte, J., Carpenito, C., Wood, T., et al. (2013) · Human Gene Therapy · doi:10.1089/hum.2012.172 · Cited by 126 · cited 1×
“We posit that by using an uncharacterized population, subgroups that may respond vigorously—or, alternately, poorly —are unlikely to be identified within the context of the entire experimental group [59–63].”
Background
Cited by
Lambert, N., Strebel, P., Orenstein, W., Icenogle, J., & Poland, G. A. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60539-0 · Cited by 304
Self-citationVaccines, adjuvants and autoimmunity
Guimarães, L. E., Baker, B., Perricone, C., & Shoenfeld, Y. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.08.003 · Cited by 262
Ovsyannikova, I. G., Haralambieva, I. H., Crooke, S. N., Poland, G. A., & Kennedy, R. B. (2020) · Immunological Reviews · doi:10.1111/imr.12897 · Cited by 258
Self-citationCurrent Challenges in Vaccinology
Kennedy, R. B., Ovsyannikova, I. G., Palese, P., & Poland, G. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01181 · Cited by 113
“Vaccine safety is also being addressed using genetic approaches—termed “adversomics”—using the tools of immunogenomics, systems biology, computational modeling, and bioinformatics in order to better understand both genetic and non-genetic drivers of aberrant vaccine responses at the molecular level (7, 171, 172, 176).”
BackgroundMethodInfluentialSelf-citationSalk, H. M., Simon, W. L., Lambert, N. D., Kennedy, R. B., Grill, D. E., Kabat, B. F., & Poland, G. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162803 · Cited by 75
“Further studies using systems biology approaches to understand the mechanisms that allow for increased species richness after vaccination, as well as the colonization of the particular bacterial species associated with increased influenzaspecific titers post-vaccination, could significantly advance the field of vaccin…”
BackgroundImmune response to vaccines in children with celiac disease
Anania, C., Olivero, F., Spagnolo, A., Chiesa, C., & Pacifico, L. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i18.3205 · Cited by 20
Metadata
- Authors
- Poland, G. A., Kennedy, R. B., McKinney, B. A., Ovsyannikova, I. G., Lambert, N. D., Jacobson, R. M., & Oberg, A. L.
- Venue
- Seminars in Immunology
- Publisher
- Elsevier BV
- Published
- 2013-04
- Volume
- 25
- Issue
- 2
- Pages
- 89-103
- ISSN
- 1044-5323 (ISSN-L)
- OpenAlex
- W2073151530
- Cited by
- 122
- References
- 8
- FWCI
- 5.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.